Skip to main content
. 2019 Mar 6;39(3):BSR20181786. doi: 10.1042/BSR20181786

Figure 3. AKT and Wnt/β-catenin signaling pathways are down-regulated by ABT263 and AXIT combination in KRAS-mutant colon cancer cells.

Figure 3

(A) Western blots of p-AKT and p-ERK for HCT116 cells treated by single or combination drugs. (B) Western blots of p-AKT and p-ERK for HCT15 cells treated by single or combination drugs. (C) Western blots of p-β-catenin, p-AKT, and p-GSK3β for HCT116 cells treated by single or combination drugs. (D) Western blots of p-β-catenin, p-AKT, and p-GSK3β for HCT15 cells treated by single or combination drugs.